Evidence map›Paper›PMID 28816720›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2017

Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037.

Florence Momplaisir, Mustafa Hussein, Danielle Tobin-Fiore, Laramie Smith, David Bennett, Carl Latkin, David S Metzger

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Florence Momplaisir*Division of Infectious Diseases and HIV Medicine, Drexel College of Medicine, Philadelphia, PA; †Public Health Policy and Administration, Joseph J. Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI; ‡Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; §Division of Public Health, UC San Diego School of Medicine, San Diego, CA; ‖Department of Psychiatry, Drexel, College of Medicine, Philadelphia, PA; and ¶Department of Health, Behavior, and Society, School of Public Health, Johns Hopkins University, Baltimore, MD.
Mustafa Hussein
Danielle Tobin-Fiore
Laramie Smith
David Bennett
Carl Latkin
David S Metzger
Drexel University · USUniversity of Pennsylvania · USUC San Diego Health System · USUniversity of Wisconsin–Milwaukee · US

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
HIV Treatment and Substance Use in LMIC Shaping MSMs Sociostructural ContextK01DA039767 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, LARAMIE RAE · 2015 to 2019
$906k
NIAID NIH HHS UM1 AI068619NIDA NIH HHS K01 DA039767
6 · The paper itself

Abstract

backgroundHIV prevention interventions in the United States have failed to eliminate racial inequities. Here, we evaluate factors associated with racial inequities in HIV prevalence among people who inject drugs using HIV Prevention Trial Network 037 data.

methodsWe measured racial homophily (ie, all members share the same race), being in an HIV+ network (network with ≥1 HIV+ member), and drug and sex risk behaviors. A 2-level logistic regression with a random intercept evaluated the association between being in an HIV+ network and race adjusting for individual-level and network-level factors.

resultsData from 232 index participants and 464 network members were included in the analysis. Racial homophily was high among blacks (79%) and whites (70%); 27% of all-black, 14% of all-white, and 23% of racially mixed networks included HIV+ members. Sex risk was similar across networks, but needle sharing was significantly lower in all-black (23%) compared with all-white (48%) and racially mixed (46%) networks. All-black [adjusted odds ratio (AOR), 3.6; 95% confidence interval (CI), 1.4 to 9.5] and racially mixed (AOR, 2.0; 95% CI: 1.1 to 3.7) networks were more likely to include HIV+ network members; other factors associated with being in HIV+ network included homelessness (AOR, 2.0; 95% CI, 1.2 to 3.2), recent incarceration (AOR, 0.4; 95% CI, 0.2 to 0.7), and cocaine injection (AOR, 1.7; 95% CI, 1.0 to 2.7). Risk behaviors were not associated with being in an HIV+ network.

conclusionDespite having lower drug risk behavior, all-black networks disproportionately included HIV+ members. HIV prevention interventions for people who inject drugs need to go beyond individual risk and consider the composition of risk networks.

Indexed as

Health Status DisparitiesAdultBlack or African AmericanEducational StatusFemaleHealthcare DisparitiesHispanic or LatinoHIV InfectionsHumansMalePhiladelphiaPopulation SurveillancePrevalencePrisonersRisk-TakingSexual Behavior

Identifiers

PMID28816720
PMCPMC5884106
OpenAlexW2750088467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.